Sanofi is a global pharmaceutical company committed to improving access to healthcare and supporting the patients we serve throughout the continuum of care.
The Sanofi iDEA-TECH Awards initiative is designed to innovate through collaborations, with a focus on cutting-edge digital and data tools and new technologies for R&D applications. The goal is to:
- Identify new projects and help develop new approaches and translational technologies from key academic institutions and start-ups
- De-risk cutting-edge science and technologies that can bring high potential value to R&D
- Build strong relationships with new partners that can lead to longer-term partnerships
Each selected Investigator will receive up to $150K USD, have a dedicated Sanofi scientific expert assigned to the project for 1-year and gain privileged access to developing an extended collaboration.
Sanofi’s main objectives in creating the iDEA-TECH Awards program are to rapidly start one-year projects that maximize the opportunity for continued collaborations of mutual interest.
Areas of Interest:
- DDS - Data & Data Sciences
- LMR - Large Molecules Research
- GMU - Genomic Medicine Unit
- Pre-Clinical Safety
- DMPK - Drug Metabolism and Pharmacokinetics
- PMCB – Precision Medicine Computational Biology
- Translational In Vivo Models
- RWE - Real World Evidence Development
- IDD - Integrated Drug Discovery
- CMC – Chemistry Manufacturing and Controls
- Vaccines
iDEA-TECH Awards 2023-2024 is open to academic institutions across North America and start-ups. For more information on iDEA-TECH Awards in general, here is the link to their dedicated website: Sanofi iDEA-iTECH Awards North America
Submission portal link: iDEA-TECH North America 2023
For help applying or questions about the call for projects, please email Swapneeta Date at